MXCT

At a glance

Maxcyte Inc (MXCT) is listed on NASDAQ and classified in Medical Devices, part of the Healthcare sector. It is headquartered in Rockville, United States and has 91 employees. The company is worth $147.58M. Revenue was $33.03M in fiscal 2025, down 14.5% from the year before. It reported a net loss of $44.63M. The share price is 20.8% below its 52-week high of $1.81. 6 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Renaissance Technologies, at $2.35M. In that quarter, 2 of them opened or added to the position. No open-market insider trades in it were filed over the last 30 days.

Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.

Key metrics

Market cap

$147.58M

P/E

—

Forward P/E

—

P/B

1.0x

Dividend yield

0.00%

Payout

—

EPS

-$0.34

ROE

-20.39%

Profit margin

-114.77%

Revenue growth

-14.50%

Beta

1.49

52-week high

$1.81

52-week low

$0.64

History

Year by year, from the annual reports; dividends from the payments themselves.

Investors holding this

Major managers that reported this stock in their latest 13F.

• RT
  Renaissance TechnologiesHeld

  Renaissance Technologies · Q2 2026
  $2.35M

  1.91M shares · 0.0% of portfolio
• CA
  Cliff AsnessHeld

  AQR Capital Management · Q2 2026
  $2.32M

  1.88M shares · 0.0% of portfolio
• TS
  Two Sigma+ Added

  Two Sigma Investments · Q2 2026
  $1.8M

  1.46M shares · 0.0% of portfolio

Indicators, year by year

The last 5 closed years, each at that year’s closing price and reported numbers.

Others in the same sector

Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.

About the company